ABSTRACT
Background. The electrocardiographically quantified QRS duration measures ventricular depolarization and conduction. QRS prolongation has been associated with poor heart failure prognosis and cardiovascular mortality, including sudden death. While previous genome-wide association studies (GWAS) have identified 32 QRS SNPs across 26 loci among European, African, and Asian-descent populations, the genetics of QRS among Hispanics/Latinos has not been previously explored. Methods. We performed a GWAS of QRS duration among Hispanic/Latino ancestry populations (n=15,124) from four studies using 1000 Genomes imputed genotype data (adjusted for age, sex, global ancestry, clinical and study-specific covariates). Study-specific results were combined using fixed-effects, inverse variance-weighted meta-analysis. Results.
We identified six loci associated with QRS (P<5x10 -8 ), including two novel loci: MYOCD, a nuclear protein expressed in the heart, and SYT1, an integral membrane protein. The top association in the MYOCD locus, intronic SNP rs16946539, was found in Hispanics/Latinos with a minor allele frequency (MAF) of 0.04, but is monomorphic in European and African descent populations. The most significant QRS duration association was for intronic SNP rs3922344 (P= 8.56x10 -26 ) in SCN5A/SCN10A. Three additional previously identified loci, CDKN1A, VTI1A, and HAND1, also exceeded the GWAS significance threshold among Hispanics/Latinos. A total of 27 of 32 previously identified QRS duration SNPs were shown to generalize in Hispanics/Latinos.
Conclusions.
Our QRS duration GWAS, the first in Hispanic/Latino populations, identified two new loci, underscoring the utility of extending large scale genomic studies to currently under-examined populations.
INTRODUCTION
The duration of the QRS complex, obtained using a resting, standard 12-lead electrocardiogram (ECG), represents the electrical depolarization of the ventricles as an impulse travels through the cardiac conduction system and the ventricular myocardium.
Delay in cardiac ventricular conduction results in increased QRS duration, and has been shown to predict heart failure prognosis (1, 2) , sudden death (3), and cardiovascular (CV) mortality in patients with and without left ventricular dysfunction, independent of traditional CV risk factors (4) . In turn, shortening of the QRS duration with the use of cardiac-resynchronization therapy (CRT) has been shown to decrease heart-failure related events in patients with QRS prolongation (5) .
To date, heritability estimates of QRS duration have varied with up to ~40% heritability found in more recent studies (6) (7) (8) (9) . While previous genome-wide association studies have predominantly focused on European populations (10) (11) (12) , there have been several smaller studies of Asian (13, 14) , Pacific Islander (15) , and African American populations (16, 17) . Collectively, these GWAS analyses have identified 32 SNPs across 26 loci associated with QRS duration. These loci harbor ion channel and transcription factor genes involved in cardiac conduction, including SCN5A, SCN10A, TBX3, TBX5, TBX20, and HAND1 (10) (11) (12) (13) (14) (15) (16) (17) . To our knowledge, there has been no GWAS performed to study the genetics of QRS duration in Hispanic/Latino ancestry populations. We therefore performed a GWAS of QRS duration in four Hispanic/Latino study populations: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the Multi-Ethnic Study of Atherosclerosis (MESA), the Starr County Study (Starr), and the Women's Health Initiative (WHI).
RESULTS
Our GWAS included 15,124 Hispanic/Latino individuals from four contributing cohorts.
Baseline characteristics varied substantially across the four cohorts. Notably, WHI is a study of women only. The average age of the participants across the four cohorts ranged from 45 to 61 years. The prevalence of hypertension and diabetes across the four cohorts ranged from 26% to 42% for hypertension and 8% to 46% for diabetes (Supplementary Table 1 ).
Genome-wide Association Analysis
Following quality control (see Materials and Methods), individual studies contributed between 5.8M and 20.2M individual SNPs, yielding 21.1M combined, unique SNPs overall. Neither the individual studies (λ range=0.96-1.03) nor the combined metaanalysis (λ=1.03) exhibited evidence of test-statistic inflation ( Supplementary Figures 1   and 2 ). SNPs in six loci exceeded the genome-wide threshold for significance (Table 1, Figure 1 ). Two of the loci (MYOCD and SYT1) were novel, whereas the remaining four (SCN5A-SCN10A, HAND1, CDKN1A, and VTI1A) were previously identified in other ethnic groups. There was no evidence of heterogeneity (Cochran's Q test P-value>0.05, Supplementary Table 2), and effect direction was consistent across all contributing studies for all index SNPs (Supplementary Figure 3) . All index SNPs were either directly genotyped or were of high imputation quality (Supplementary Table 3) .
Novel Associations
The meta-analysis identified two novel loci (MYOCD and SYT1) associated with QRS duration. The index SNP (rs16946539) in MYOCD (myocardin, a nuclear protein found in cardiac and smooth muscle), as well as the only SNP (rs139859815) in high LD (r 2 >0.5) with it, are monomorphic in the European-descent and African-descent 1000
Genomes super populations (Supplementary Table 4 ).
The second novel locus was on chromosome 12 near SYT1 (synaptotagmin-1), an integral membrane protein of synaptic vesicles that responds to calcium signaling. The index SNP in SYT1 (rs4842438) was examined in both European and African ancestry GWAS efforts, but failed to reach nominal significance (P>0.05; Figure 3) . Indeed, the effect size of rs4842438 in Hispanics/Latinos (beta=1.04 ms) is statistically larger than in European-descent (beta=0.13 ms) and African-descent (beta=0.00 ms) individuals (P for difference=5.69x10 -5 and 8.65x10 Hispanic/Latino MAF=0.07).
SCN5A-SCN10A
The most significant association with QRS duration was found in chromosome region 3p22 (rs3922844) in locus 1, bridging SCN5A and SCN10A, two adjacent cardiac sodium-channel genes ( Figure 2 ). This SNP had previously been found to be genomewide significant among European and African American descent individuals (Supplementary Tables 5 and 6 ). Similar to our findings in Hispanics/Latinos, rs3922844
is the most significantly associated QRS SNP in African Americans ( Figure 2 ). In contrast, among European-descent individuals, the strongest SNP association 
Additional Hispanic/Latino Associations in Known Loci
Three additional previously discovered SNP-QRS associations were also found in Hispanics/Latinos. These include intronic SNPs within CDKN1A and VTI1A, and an intergenic SNP near HAND1. While the Hispanic/Latino index SNP in CDKN1A
(rs3176326) was not directly evaluated in the European or African American GWAS, it was in high LD with a SNP that had been found to be highly significant in the previous European ancestry GWAS (r 
Transethnic Analyses: Generalization
We examined association of 32 index SNPs from published GWAS analyses (27 European,1 African-American, 2 East Asian, and 2 from a meta-analysis of the European and African American GWAS results) for association with QRS duration among Hispanics/Latinos (11, 13, 17) (Supplementary Table 8 , Figure 4 ). Of the 32 previously identified independent SNPs, 27 generalized in Hispanics/Latinos (r-value <0.05). These included 26 of the 27 SNPs from the European GWAS, with rs1362212
as the exception (Supplementary Table 8 ).
Transethnic Analyses: Effect Size
We then compared the effect sizes of the independent index SNPs identified in Table   7 ).
Cross Phenotype Analyses
The 9 index SNPs identified in the Hispanic/Latino QRS duration GWAS were also examined for their association with other ECG phenotypes: QT duration (18), PR duration (19) , heart rate (20) , and a measure of heart rate variability, the standard deviation of normal to normal R-R intervals (SDNN) (20) ( Table 2, Supplementary Table   9 ). The 4 SNPs in the SCN5A-SCN10A locus were genome-wide significantly associated with both QT and PR interval duration, with SNPs that prolong QRS also prolonging the PR interval but conversely shortening QT duration. This pattern was also observed in the CDKN1A locus. However, the index SNPs rose only to a Bonferroni corrected significance level for QT duration, and fell just under significance for PR duration (P=1.44E-03). Intriguingly, the novel MYOCD locus was significantly associated with PR duration at the Bonferroni corrected significance level, with the SNP that prolongs QRS duration shortening PR duration. None of the QRS index SNPs were significantly associated with heart rate or SDNN.
Functional Annotation
The function for all 9 index SNPs was investigated using the HaploReg 4.1 web server (21) . Functional information was obtained for 3 loci: SCN5A-SCN10A, CDKN1A, and MYOCD. SNPs in CDKN1A showed evidence for activating transcription in heart tissues, including fetal heart tissue, the right atrium, the right ventricle, and the left ventricle. SCN5A-SCN10A and MYOCD SNPs were identified as possible enhancers of transcription in the same heart tissues (Supplementary Table 10 ).
DISCUSSION
Our GWAS meta-analysis of four cohorts containing 15,124 individuals of Hispanic/Latino ethnicity found 9 index SNPs across 6 loci with genome-wide significant associations with QRS duration. Two loci were novel (MYOCD and SYT1) and four of the loci (SCN5A-SCN10A, CDKN1A, HAND1, and VTI1A) were previously identified in QRS GWAS analyses of European- (11) and African-descent (17) The second novel locus found in this study involved an intronic SNP in SYT1.
Interestingly, a different synaptotagmin gene, SYT10, was previously associated with heart rate (26). The SYT1 intronic SNP was not associated with heart rate in our study.
It is noteworthy that this SNP in SYT1 showed no evidence of association with QRS ).
Furthermore, while we excluded individuals with QRS duration longer than 120 ms in order to exclude individuals who have conduction defects and/or bundle branch blocks due to acquired heart disease, interesting genetic associations may be missed by this approach.
In conclusion, our findings indicate that the genetics of QRS duration are largely similar between ethnic groups. However, important differences do exist, illustrated, for instance, by the novel genome-wide significant SNP in MYOCD that is monomorphic in both Europeans and African Americans. Our study underscores the importance of conducting genetic studies in diverse and under-examined populations, such as Hispanics/Latinos, to uncover novel loci.
MATERIALS AND METHODS

Study Population -Primary meta-analysis of individuals with Hispanic/Latino ancestry
Our meta-analysis included 15,124 participants of self-identified Hispanic/Latino descent from the following four studies: the HCHS/SOL (n=11,566), the Multi-Ethnic
Study of Atherosclerosis (MESA, n=1431), the Starr County Study (n=582), and the WHI (n=1545) (see Supplementary Material for cohort description and Supplementary Table 1 for baseline characteristics by cohort). Ancestry was confirmed through principal components analysis, and a small number of genetic outliers (individuals determined to be of primarily Asian ancestry) were excluded.
Study Population -Comparison meta-analyses of individuals with European and
African ancestry
Comparisons of results were made between the Hispanic/Latino meta-analysis, and two published meta-analyses of QRS duration in individuals of European (n=40,407) and African American (n=13,301) ancestries. Details of these studies can be obtained from their original publications (11, 17) .
Electrocardiography
Participants in each of the four cohorts underwent a standard 12-lead ECG by a certified technician (see Supplementary Table 11 ). Participants were excluded from further analysis if they had any of the following: poor quality ECGs, atrial flutter or fibrillation, a ventricular paced rhythm, QRS duration ≥ 120 ms, Wolff-Parkinson-White on ECG, a history of previous myocardial infarction or heart failure, or were taking class I or class III antiarrhythmic medications.
Genotyping and imputation
HCHS/SOL participants were genotyped on an Illumina custom array that included the Illumina Omni 2.5M array (HumanOmmni2.5-8v1-1) and an additional ~150,000 SNPs.
The additional SNPs were chosen to contain markers relevant to Hispanic/Latino ancestry, markers informative of Native American ethnicity, and significant loci from previous association studies (21) . MESA, WHI, and Starr County participants were genotyped using the Affymetrix Genome-Wide Human SNP Array 6.0. SNP genotyping inclusion criteria varied slightly across studies. After individual cohort genotype QC, imputation based on the 1000 Genomes phase 1 reference panel (27) was performed resulting in roughly 38 million SNPs (Supplementary Table 11 ).
Statistical Analysis
To assess the association between genotype and QRS duration, individual cohort studies used additive genetic linear regression models, either in a regression model (MESA, WHI, Starr County) or a mixed model (HCHS/SOL, to account for relatedness and shared environment between individuals). The two methods estimate the same effect. Models were adjusted for age, sex, heart rate, systolic blood pressure, BMI, height, study site/region, and principal components of genetic ancestry. After we received the results from the studies, we applied an individual cohort QC filter, which excluded SNPs with low imputation quality (<0.30) or small effective sample sizes for each individual SNP (݂݂݁ܰ <30), with
where N is the number of participants. Each cohort contained between ~6M and ~20M imputed SNPs, after applying this filter.
Results were combined using fixed-effects inverse variance meta-analysis using the METAL software package (28), using genomic control for summary statistics to reduce test-statistic inflation. Study heterogeneity was evaluated using the Cochran Q test.
Approximately 21M unique SNPs were contained in the meta-analysis. Results were considered genome-wide significant for P-values < 5x10 -8 . Secondary signals were identified using iterative rounds of conditional analysis, with adjustment for additional Hispanic/Latino index SNPs in the model, until there were no SNPs found to be genome-wide significant.
Transethnic Analyses: Generalization
Previous meta-analyses in European, East Asian, African American ancestry populations identified a total of 32 genome-wide significant SNPs. To assess whether these significant findings generalize to Hispanics/Latinos, we used the method of Sofer et al (29) . An association is considered generalized if a significant effect in the same direction exists in both the non-Hispanic/Latino discovery population as well as the Hispanic/Latino population. This method controls the false discovery rate (FDR) of the generalization null hypotheses, and generates an r-value for each SNP (with r-values < 0.05 showing evidence that an association is generalizable under FDR control at the α =0.05 level.)
Transethnic Analyses: Effect Size
Comparisons of effect size differences of SNPs on QRS duration across the Hispanic/Latino, European, and African American GWAS were done using a procedure analogous to Welch's t-tests for each of the 33 independent SNPs that were identified as having a primary or secondary independent association in any of those studies. For the purposes of Bonferroni correction, there were 29 independent SNPs available for testing in all 3 cohorts. Some SNPs were not available in all cohorts due to use of different imputation panels. Comparisons for 29 SNPs among 3 studies resulted in 87
tests. Therefore, differences in effect size were determined to be significant when
P<5.75E-04.
Cross Phenotype Analysis
Index SNPs discovered in the QRS duration analysis were also examined for associations with other ECG phenotypes, including QT, PR, heart rate, and SDNN.
These GWAS efforts were based upon the same underlying Hispanic/Latino cohorts as the QRS duration GWAS. However, due to different inclusion/exclusion criteria, differences in the study samples do exist between studies. Full details of these studies can be obtained from their original publications (18) (19) (20) . Significance for these other traits exceeded either: a genome-wide significance threshold (P<5.0E-08); Bonferroni corrected significance (P<1.39E-03 for 36 tests); or nominal significance (P<0.05).
Functional Annotation
The HaploReg v4.1 online web resource was used to functionally annotate genomewide significant SNPs (21) . HaploReg utilizes data obtained from the ENCODE (30) and RoadMap projects (31) , to give information on how SNPs might alter gene expression in diverse tissue types. We restricted our analysis to only specific heart tissues --namely, fetal heart tissue, the right atrium, the right ventricle, and the left ventricle. Based on the chromatin-15 state model, we summarized the potential function of SNPs in the genome-wide significant loci in each of the different heart tissues. For each loci, we examined primary SNPs, secondary signal SNPs, and all other SNPs in high LD (r 2 >0.80) with these SNPs. The LD structure pattern used for this analysis was the 1000
Genomes AMR Phase-1 super-population.
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